Baduanjin Lower Elevated Blood PreSsure Study

Traditional Exercise as Convenient Approach to Improve Health 1-Baduanjin Lower Elevated Blood PreSsure Study

The aim of this study is to evaluate the effects of Baduanjin on blood pressure in individuals with high normal blood pressure (SBP 130-139 mmHg, and/or DBP 85-89 mmHg), as well as on glucose and lipid metabolism, quality of life, psychology, exercise, immune inflammation, endothelial function, and arterial stiffness.

Inclusion Criteria:

• Age 40 years or older;
• Systolic blood pressure (SBP) <140 mmHg and diastolic blood pressure (DBP) <90 mmHg
• SBP 130-139 mmHg, and/or DBP 85-89 mmHg

Exclusion Criteria:

• Diagnosis of hypertension (SBP≥140 mmHg, and/or DBP ≥90mmHg）
• History of cardiovascular diseases, such as coronary heart disease, heart failure, stroke, and peripheral vascular disease
• Diagnosis of chronic kidney disease, primary aldosteronism, Cushing's syndrome, or pheochromocytoma
• Newly diagnosed cancer or cancer metastasis within 5 years
• History of autoimmune disease
• Having taken antihypertensive drugs or immunoregulators within 2 weeks
• A long-term need for antihypertensive drugs or immunomoregulators
• Unable to maintain moderate intensity exercise due to illness or other reasons
• Pregnant, breastfeeding, or planning to become pregnant within the next 1 year
• Currently taking regular exercise (at least 30 minutes of moderate-intensity exercise at least three times a week)
• Allergic to sports bracelets
• Having participated or been participating in other clinical trials within the last 3 months
• Unable to use smartphones
• Other factors that may affect the follow-up, such as alcohol or substance abuse in the last 12 months, planing to live out of town for a long time, or diagnosis of dementia or cognitive impairment which indicates incapability of completing the study
• Unable to accurately measure blood pressure using the sphygmomanometer provided by the study due to a too large or too small arm circumference